Earnings Call · Q4 FY2023·2024-02-29

Q4 23EPS +14.81%·Rev n/aQ3 23EPS -100.00%*·Rev n/aQ2 23EPS -19.51%·Rev n/aQ1 23EPS -16.13%·Rev n/a⚠ consensus missing

CATALYST PHARMACEUTICALS, INC. CPRX

Michael Kalb — Investor Relations or similar role (host) inferred from context

Richard Daly — Chief Executive Officer

Jeffrey Del Carmen — Likely Chief Financial Officer or similar financial role inferred from discussing financials

Steven Miller — Chief Operating Officer

+10.1%1d on move date+9.7% vs SPY3d+14.6%5d+8.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPRX calls or request research access.

More CPRX calls Browse calls Request research access